Source map — mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| CNBC | news | 60% |
| Bloomberg.com | news | 60% |
| The New York Times | news | 60% |
| Ars Technica | news | 60% |
| Yahoo Finance | news | 60% |
| pharmaphorum.com | news | 50% |
| globalhealthcaremagazine.com | news | 50% |
| www.medscape.com | news | 50% |
| health.yahoo.com | news | 50% |
| www.theweek.in | news | 50% |
| cde.news | news | 50% |
| stocktwits.com | news | 50% |
| www.biospectrumasia.com | news | 50% |
| en.wikipedia.org | news | 50% |
| my.clevelandclinic.org | news | 50% |
| www.genome.gov | gov | 50% |
| www.civilbeat.org | news | 50% |
| www.statnews.com | news | 50% |
| guavy.com | news | 50% |
| lacrossetribune.com | news | 50% |
| marketchameleon.com | news | 50% |
| cepa.org | news | 50% |
| phillyfightscancer.org | news | 50% |
| arstechnica.com | news | 50% |
| www.wbur.org | news | 50% |
| www.nationalgeographic.com | news | 50% |
| www.smithsonianmag.com | news | 50% |
| www.medicalnewstoday.com | news | 50% |
| moneymorning.com | news | 50% |
| medicalxpress.com | news | 50% |
| en.protothema.gr | news | 50% |
| www.sciencenews.org | news | 50% |
| www.usatoday.com | news | 50% |
| www.merck.com | news | 50% |
| san.com | news | 50% |
| www.nature.com | news | 50% |
| jen.jiji.com | news | 50% |
| finance.yahoo.com | news | 50% |
| finance.biggo.com | news | 50% |
| www.biospace.com | news | 50% |
| www.pymnts.com | news | 50% |
| www.elle.com | news | 50% |